University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Yvonne Huang, M.D.

Pulmonologist

Dr. Yvonne Huang is a pulmonary and critical care specialist and serves as the associate director of the UCSF Adult Cystic Fibrosis Program. Huang conducts research focused on understanding the nature of microbial populations that reside in disease-affected lungs and the relationships between this lung microbiome and chronic inflammatory airway diseases, such as asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Huang has been interested in investigating the links between lung microbial community composition and their influence on clinical disease presentation or response to therapies, which can vary greatly among patients with the same diseases.

Huang received her undergraduate degree from Stanford University and her medical degree from the University of Alabama at Birmingham. She completed training in internal medicine at Yale, where she was recognized as a Yale/Johnson & Johnson Physician Scholar in international health.She then completed a clinical fellowship in pulmonary and critical care medicine at UCSF. Huang completed postdoctoral research training on the lung microbiome. She joined the faculty as an assistant professor in 2011.

Clinics

Cystic Fibrosis Center
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143-0359
Phone: (415) 353-2961
Fax: (415) 353-2568

Hours: Monday to Friday
8 a.m. – 5 p.m.

Pulmonary Practice at Parnassus
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143-0359
Phone: (415) 353-2961
Fax: (415) 353-2568

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

  • Asthma
  • Cystic Fibrosis

More about Yvonne Huang

Education

University of Alabama School of Medicine 2001

Residencies

Yale New-Haven Medical Center 2004

Fellowships

UCSF Medical Center, Pulmonary/Critical Care Medicine 2008

Selected Research and Publications

  1. Huang YJ, Boushey HA. The bronchial microbiome and asthma phenotypes. Am J Respir Crit Care Med. 2013 Nov 15; 188(10):1178-80.
  2. Huang YJ. Asthma microbiome studies and the potential for new therapeutic strategies. Curr Allergy Asthma Rep. 2013 Oct; 13(5):453-61.
  3. Huang YJ, Charlson ES, Collman RG, Colombini-Hatch S, Martinez FD, Senior RM. The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. Am J Respir Crit Care Med. 2013 Jun 15; 187(12):1382-7.
  4. Huang YJ, Lynch SV, Wiener-Kronish JP. From microbe to microbiota: considering microbial community composition in infections and airway diseases. Am J Respir Crit Care Med. 2012 Apr 1; 185(7):691-2.
  5. Han MK, Huang YJ, Lipuma JJ, Boushey HA, Boucher RC, Cookson WO, Curtis JL, Erb-Downward J, Lynch SV, Sethi S, Toews GB, Young VB, Wolfgang MC, Huffnagle GB, Martinez FJ. Significance of the microbiome in obstructive lung disease. Thorax. 2012 May; 67(5):456-63.
  6. Huang YJ, Lynch SV. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med. 2011 Dec; 5(6):809-21.
  7. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J, Wiener-Kronish JP, Sutherland ER, King TS, Icitovic N, Martin RJ, Calhoun WJ, Castro M, Denlinger LC, Dimango E, Kraft M, Peters SP, Wasserman SI, Wechsler ME, Boushey HA, Lynch SV. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol. 2011 Feb; 127(2):372-381.e1-3.
  8. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE, Wu B, Tran D, Koff J, Kleinhenz ME, Nielson D, Brodie EL, Lynch SV. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One. 2010; 5(6):e11044.
  9. Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, Wiener-Kronish JP, Lynch SV. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS. 2010 Feb; 14(1):9-59.
  10. Cox MJ, Huang YJ, Fujimura KE, Liu JT, McKean M, Boushey HA, Segal MR, Brodie EL, Cabana MD, Lynch SV. Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome. PLoS One. 2010; 5(1):e8745.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.